Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


25.03.2024

1 Am J Respir Crit Care Med
1 Ann Surg Oncol
2 Ann Thorac Surg
3 Br J Cancer
2 Cancer
2 Cancer Res
1 Cancer Sci
1 Eur J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Clin Invest
1 J Comput Assist Tomogr
1 J Natl Cancer Inst
1 J Thorac Cardiovasc Surg
2 J Thorac Oncol
1 JAMA Oncol
1 Lung Cancer
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Thorax


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. GONZALEZ AV, Silvestri GA, Korevaar DA, Gesthalter YB, et al
    Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Ch
    Am J Respir Crit Care Med. 2024;209:634-646.
    PubMed         Abstract available


    Ann Surg Oncol

  2. GRENDA TR
    Refocusing the Prognosis Lens: Conditional Survival After Surgery in Limited-Stage Small Cell Lung Cancer.
    Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168.
    PubMed        


    Ann Thorac Surg

  3. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
    STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
    PubMed         Abstract available

  4. FERRARIS VA
    Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
    PubMed        


    Br J Cancer

  5. BARANYI M, Molnar E, Hegedus L, Gabriel Z, et al
    Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.
    Br J Cancer. 2024;130:1059-1072.
    PubMed         Abstract available

  6. REN Z, Dharmaratne M, Liang H, Benard O, et al
    Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1alpha.
    Br J Cancer. 2024 Jan 18. doi: 10.1038/s41416-023-02522.
    PubMed         Abstract available

  7. GORGULHO J, Roderburg C, Beier F, Bokemeyer C, et al
    Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies.
    Br J Cancer. 2024;130:1013-1022.
    PubMed         Abstract available


    Cancer

  8. WISNIVESKY JP, Mudd J, Stone K, Slatore CG, et al
    Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Cancer. 2024 Mar 21. doi: 10.1002/cncr.35286.
    PubMed         Abstract available

  9. AJABNOOR AM, Parisi R, Zghebi SS, Ashcroft DM, et al
    Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019.
    Cancer. 2024;130:1316-1329.
    PubMed         Abstract available


    Cancer Res

  10. GAI X, Liu Y, Lan X, Chen L, et al
    Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer.
    Cancer Res. 2024 Mar 19. doi: 10.1158/0008-5472.CAN-23-2095.
    PubMed         Abstract available

  11. MU M, Huang CX, Qu C, Li PL, et al
    Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1796.
    PubMed         Abstract available


    Cancer Sci


  12. Correction to: Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
    Cancer Sci. 2024 Mar 20. doi: 10.1111/cas.16163.
    PubMed        


    Eur J Cancer

  13. LEONETTI A, Perrone F, Puntoni M, Maglietta G, et al
    Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
    Eur J Cancer. 2024;202:114006.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  14. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    PubMed         Abstract available

  15. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
    BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
    PubMed         Abstract available

  16. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  17. GE Y, Zhan Y, He J, Li J, et al
    PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in PD-L1-negative metastatic lung adenocarcinoma: a real-world data.
    J Cancer Res Clin Oncol. 2024;150:135.
    PubMed         Abstract available

  18. BANAT M, Potthoff AL, Hamed M, Borger V, et al
    Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
    J Cancer Res Clin Oncol. 2024;150:136.
    PubMed         Abstract available


    J Clin Invest

  19. PEYVANDI S, Bulliard M, Yilmaz A, Kauzlaric A, et al
    Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL6-JAK-induced cancer cell plasticity.
    J Clin Invest. 2024 Jan 18:e166847. doi: 10.1172/JCI166847.
    PubMed         Abstract available


    J Comput Assist Tomogr

  20. HU Y, Geng Y, Wang H, Chen H, et al
    Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.
    J Comput Assist Tomogr. 2024 Mar 18. doi: 10.1097/RCT.0000000000001591.
    PubMed         Abstract available


    J Natl Cancer Inst

  21. FUCITO LM, Palmer AM, Baldassarri SR
    A new perspective on mitigating lung cancer risks through smoking cessation and reduction.
    J Natl Cancer Inst. 2024 Mar 18:djae044. doi: 10.1093.
    PubMed        


    J Thorac Cardiovasc Surg

  22. RUSCH VW
    Commentary: "Real world" neoadjuvant immunochemotherapy for lung cancer:Additional data but still many questions.
    J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00209.
    PubMed        


    J Thorac Oncol

  23. TRAVIS WD, Eisele M, Nishimura KK, Aly R, et al
    The IASLC Lung Cancer Staging Project: Recommendation to Introduce Spread Through Air Spaces (STAS) as a Histologic Descriptor in the 9(th) Edition of the TNM Classification of Lung Cancer.Analysis of 4,061 Pathologic Stage I Non-Small cell Lung Carci
    J Thorac Oncol. 2024 Mar 18:S1556-0864(24)00122.
    PubMed         Abstract available

  24. BORGEAUD M, Parikh K, Banna GL, Kim F, et al
    Unveiling the Landscape of uncommon EGFR Mutations in Non-Small Cell Lung Cancer - A Systematic Review.
    J Thorac Oncol. 2024 Mar 16:S1556-0864(24)00123.
    PubMed         Abstract available


    JAMA Oncol

  25. KEREKES DM, Frey AE, Prsic EH, Tran TT, et al
    Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US.
    JAMA Oncol. 2024;10:342-351.
    PubMed         Abstract available


    Lung Cancer

  26. WALLACE ND, Alexander M, Xie J, Ball D, et al
    The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Lung Cancer. 2024;190:107531.
    PubMed         Abstract available


    PLoS One

  27. ZHANG L, Xu L, Chen Z, You H, et al
    Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patients.
    PLoS One. 2024;19:e0297742.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. HAN X, Wang D, Yang L, Wang N, et al
    Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2319429121.
    PubMed         Abstract available


    Thorax

  29. JACOBS C
    Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?
    Thorax. 2024;79:293-294.
    PubMed        

  30. WARKENTIN MT, Al-Sawaihey H, Lam S, Liu G, et al
    Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
    Thorax. 2024;79:307-315.
    PubMed         Abstract available

  31. ROSTOCK L, Holotiuk O, Ploenes T
    Well-differentiated papillary mesothelial tumour: a rare finding on the pleura.
    Thorax. 2024;79:380-381.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.